Two novel ligand-independent variants of the vegfr-1 receptorare expressed in human testis and spermatozoa, one of them with the ability to activate src proto-oncogene tyrosine kinases

Belen Alvarez-Palomo, Carme Barrot-Feixat, Helena Sarret, Jordi Requena, Montserrat Pau, Jose Manuel Vidal-Taboada, Rafael Oliva, Josep Lluis Ballesca, Michael J. Edel, Jovita Mezquita-Pla

Research output: Contribution to journalArticle

Abstract

The vascular endothelial growth factor receptor 1 (VEGFR-1) family of receptors is preferentially expressed in endothelial cells, with the full-length and mostly the soluble (sVEGFR-1) isoforms being the most expressed ones. Surprisingly, cancer cells (MDA-MB-231) express, instead, alternative intracellular VEGFR-1 variants. We wondered if these variants, that are no longer dependent on ligands for activation, were expressed in a physiological context, specifically in spermatogenic cells, and whether their expression was maintained in spermatozoa and required for human fertility. By interrogating a human library of mature testis cDNA, we characterized two new truncated intracellular variants different from the ones previously described in cancer cells. The new isoforms were transcribed from alternative transcription start sites (aTSS) located respectively in intron-19 (i19VEGFR-1) and intron-28 (i28VEGFR-1) of the VEGFR-1 gene (GenBank accession numbers JF509744 and JF509745) and expressed in mature testis and spermatozoa. In this paper, we describe the characterization of these isoforms by RT-PCR, northern blot, and western blot, their preferential expression in human mature testis and spermatozoa, and the elements that punctuate their proximal promoters and suggest cues for their expression in spermatogenic cells. Mechanistically, we show that i19VEGFR-1 has a strong ability to phosphorylate and activate SRC proto-oncogene non-receptor tyrosine kinases and a significant bias toward a decrease in expression in patients considered infertile by WHO criteria.

Original languageEnglish
Pages (from-to)5871-5887
Number of pages17
JournalOncotarget
Volume10
Issue number56
Publication statusPublished - 1 Oct 2019

    Fingerprint

Cite this

Alvarez-Palomo, B., Barrot-Feixat, C., Sarret, H., Requena, J., Pau, M., Vidal-Taboada, J. M., ... Mezquita-Pla, J. (2019). Two novel ligand-independent variants of the vegfr-1 receptorare expressed in human testis and spermatozoa, one of them with the ability to activate src proto-oncogene tyrosine kinases. Oncotarget, 10(56), 5871-5887.